Respiratory infections and asthma

Medical Journal of Australia

Volumn 177, Issue 6 SUPPL., 2002, Pages

  Isaacs, David ^a,b   Joshi, Preeti ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MACROLIDE;

ASTHMA; ATOPY; AUSTRALIA; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CHILD; CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; COMMUNICABLE DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CORONAVIRUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; INFANT; INFLUENZA VIRUS; MYCOPLASMA; MYCOPLASMA PNEUMONIAE; NATIVE SPECIES; NONHUMAN; PARAINFLUENZA VIRUS; PATHOGENICITY; PEAK EXPIRATORY FLOW; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; TH1 CELL; TH2 CELL; VIRUS INFECTION; WHEEZING;

EID: 0037120585     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04816.x     Document Type: Conference Paper

References (17)

1. Johnston SL, Pattemore PK, Sanderson S, et al. Community study of role of viral exacerbations of asthma in 9-11 year old children. BMJ 1995; 310: 1225-1229.
2. Gern JE, Galagan DM, Jarjour NN, et al. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997; 155: 1159-1161.
3. Anderson GP. Therapeutic prospects for early asthma. Med J Aust 2002; 177 Suppl Sep 16: S66-S69.
4. Joshi P. A cohort study of cytokines and atopy [PhD thesis]. University of Sydney, 2001.
5. Joshi P, Kakakios A, Jayasekera J, Isaacs D. A comparison of IL-2 levels in nasopharyngeal and endotracheal aspirates of babies with respiratory syncytial viral bronchiolitis. J Allergy Clin Immunol 1998; 102: 618-620.
6. Wang S-Z, Forsyth RD. Asthma and respiratory syncytial virus infection in infancy: Is there a link? Clin Exp Allergy 1998; 28: 927-935.
7. Welliver RC. RSV and chronic asthma. Lancet 1995; 346: 789-790.
8. McConnochie KM, Roghmann KJ. Predicting clinically significant lower respiratory tract illness in childhood following mild bronchiolitis. Am J Dis Child 1985; 139: 625-631.
9. Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354: 541-545.
10. Hammerschlag MR. Chlamydia pneumoniae and the lung. Eur Respir J 2000; 16: 1001-1007.
11. Johnston SL. Is Chlamydia pneumoniae important in asthma? The first controlled trial of therapy leaves the question unanswered. Am J Respir Crit Care Med 2001; 164: 513-514.
12. Black PN, Francesco B, Jenkins R, et al. Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001; 164: 536-541.
13. Amayasu H, Yoshida S, Ebana S, et al. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma. Ann Allergy Asthma Immunol 2000; 6: 594-598.
14. File TM Jr, Tan JC, Plouffe JF. The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection. Infect Dis Clin North Am 1998; 12: 569-592.
15. Micillo E, Bianco A, D'Auria D, et al. Respiratory infections and asthma. Allergy 2000; 55(Supp 61): 42-45.
16. Von Mutius E, Illis S, Hirsch T, et al. Frequency of infections and risk of asthma, atopy and airway hyperresponsiveness in children. Eur Respir J 1999; 14: 4-11.
17. Peat JK, Veale A. Impact and aetiology of respiratory infections, asthma and airway disease in Australian Aborigines. J Paediatr Child Health 2001; 37: 108-112.